Compare

Texas Instruments/$TXN

1D1W1M3M6MYTD1Y5YMAX

About Texas Instruments

Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Ticker
$TXN
Sector
Semiconductors
Primary listing
NASDAQ
Employees
33,000
Website
www.ti.com

TXN Metrics

BasicAdvanced
$260B
43.23
$6.58
1.34
$5.68
2.00%

What the Analysts think about TXN

Analyst ratings (Buy, Hold, Sell) for Texas Instruments stock.
Analyst projections of the future price of Texas Instruments stock.

Bulls say / Bears say

A broad demand recovery is lifting several key markets: Q2 revenue rose 23% year on year, with industrial up about 30%, automotive in the mid-teens and data-centre sales doubling. TI’s Q3 revenue guidance of $5.65bn–$6.15bn points to further growth. (Texas Instruments, Texas Instruments)
TI’s in-house 300mm production offers a structural cost edge: its filing says these wafers cost about 40% less than 200mm wafers. Available clean-room space also gives it room to increase output as demand rises. (OpenCapital, Texas Instruments)
Cash generation has rebounded: trailing 12-month free cash flow was $6.5bn through June, and TI returned $5.8bn to shareholders over that period. The company expects 2026 capital spending of $2bn–$3bn, which could leave more cash available if operating momentum holds. (Texas Instruments)
Some of the automotive rebound may reflect customers replenishing stocks they had cut to unusually low levels, rather than final demand alone. A pause in restocking could take away part of recent growth. (Texas Instruments)
Free cash flow is helped by public incentives: TI reported $1.1bn in CHIPS Act proceeds in the first half of 2026. This support is policy-linked, so cash generation may look weaker if those proceeds fade. (StockTitan)
The planned $7.5bn Silicon Labs purchase adds execution and financing risk: it is partly debt-funded, requires regulatory approval and is not expected to close until the first half of 2027. Integration or approval delays could distract management and constrain cash available for shareholder returns. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2026.

TXN Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

TXN Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.